Table 2.

Clinical characteristics and associated mortality.

	Number of patients	Deaths	Mortality rate	2p-Value
Gender
Female	148	61	41.22%
Male	74	34	45.95%
Clinical frailty score
CFS ≤4	55	18	32.73%
CFS ≥5	167	77	46.11%
1	1	0	0.00%
2	7	1	14.29%
3	16	4	25.00%
4	31	13	41.94%
5	57	21	36.84%
6	72	32	44.44%
7	37	23	62.16%
8	1	1	100.00%
Place of residence
NH resident	27	21	77.78%	0.004
Residential Home	7	3	42.86%	0.7
Sheltered accommodation	8	2	25.00%	0.2
Admitted from ‘other'	2	1	50.00%	1
Own home	178	53	29.78%	<0.00001
Comorbidity
Dementia	86	43	50.00%	0.03
Cardiovascular disease	113	54	47.79%	0.5
Hypertension	125	56	44.80%	0.4
Diabetes	48	26	54.17%	0.2
COPD/Asthma	48	19	39.58%	0.7
CVCX
Not recorded	65
0	67	22	32.84%
1	32	23	71.88%
2	58	30	51.72%
Lymphocytes (×109/L)
Not recorded	23
<0.5	22	14	63.64%
0.5–1	98	45	45.92%
1.1–1.5	46	16	34.78%
>1.5	33	13	39.39%
Abnormal AST/ALT (U/L)
Not recorded	25
Yes	48	24	50.00%
No	149	64	42.95%
C-reactive protein (mg/L)
Not recorded	20
0–10	30	6	20%
11 to 50	75	22	29%
51–100	48	29	60%
101–200	34	24	71%
201–300	10	4	40%
300+	5	5	100%
Serum sodium (mmol/L)
Not recorded	20
<125	0
125–129	13	2	15.38%
130–135	33	8	24.24%
>135	156	80	51.28%
Acute kidney injury
Not recorded	20
Yes	45	28	62.22%
No	157	62	39.49%
Number of comorbidities
0	12	3	25.00%
1	80	33	41.25%
2	67	24	35.82%
3	47	24	51.06%
4	15	10	66.67%
4AT
Not recorded	39
0	48	16	33.33%
1 to 3	36	11	30.56%
≥4	99	51	51.52%